Search - tctmd.com

Displaying 61 - 71 of 71

Sort: Relevancy | Date

Presentation THT 2022

Alleviant Medical Pivotal Study Overview and Next Steps

Presenter: James Udelson

February 02, 2022

Presentation THT 2022

Alleviant Medical Technology, Procedure and Clinical Data

Presenter: Colin Barker

February 02, 2022

Presentation THT 2022

Clinical Data and Landscape of Interatrial Shunting

Presenter: Peter Fail

February 02, 2022

Presentation THT 2022

Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting

Presenter: JoAnn Lindenfeld

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation THT 2022

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Presenter: Scott Solomon

February 01, 2022

Presentation THT 2022

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Physiological Rationale and Devices for Interatrial Shunts

Presenter: JoAnn Lindenfeld

February 01, 2022

Presentation THT 2022

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Liviu Klein

February 01, 2022

Presentation THT 2022

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Roham Zamanian

February 01, 2022

Advertisement

Alleviant Medical Pivotal Study Overview and Next Steps

Alleviant Medical Technology, Procedure and Clinical Data

Clinical Data and Landscape of Interatrial Shunting

Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Physiological Rationale and Devices for Interatrial Shunts

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content